+86-27-65522453 sales@sun-shinechem.com

Obatoclax

Catalog No.: 17022707
Cas No.: 803712-79-0
Purity : 98% 
17022707 - Obatoclax | CAS 803712-79-0

Catalog number : 17022707

CAS number : 803712-79-0

Molecular Formula : C₂₁H₂₃N₃O₄S 

Molecular Weight : 413.49 

Iupac Chemical Name : Obatoclax 

Smile : Cc1cc([nH]c1/C=C\2/C(=CC(=N2)c3cc4ccccc4[nH]3)OC)C.CS(=O)(=O)O

InChiKey : ZFKXDVMHNXPEIY-PEZBNFGJSA-N

PackagingPriceAvailabilityPurityEstimated Shipping Time
BulkEnquiryEnquiry
Request Bulk Quote Download MSDSTel:+86-27-65522453 | Email:sales@sun-shinechem.com
SynonymsObatoclax Mesylate; GX15-070 
Molecular FormulaC₂₁H₂₃N₃O₄S 
Molecular Weight413.49 
Appearanceoff-white solid 
Purity98% 
SolubilitySoluble in DMSO 
Storage3 years -20ºCpowder 
Shipping ConditionShipped under ambient temperature as non-hazardous chemical. 
SmileCc1cc([nH]c1/C=C\2/C(=CC(=N2)c3cc4ccccc4[nH]3)OC)C.CS(=O)(=O)O
InChiKeyZFKXDVMHNXPEIY-PEZBNFGJSA-N
InChiInChI=1S/C20H19N3O.CH4O3S/c1-12-8-13(2)21-16(12)10-19-20(24-3)11-18(23-19)17-9-14-6-4-5-7-15(14)22-17;1-5(2,3)4/h4-11,21-22H,1-3H3;1H3,(H,2,3,4)/b19-10-;
MDLMFCD18074508
Coming soon.
Obatoclax  (GX15-070) is Bcl-2 homology domain-3 (BH3) mimetic, antagonize all antiapoptotic Bcl-2 family proteins (average IC50, 3 umol/L), including Mcl-1 (IC50, 2.9 umol/L) and Bfl-1 (IC50, 5 umol/L)

Obatoclax is a BH3 mimetic which binds to a broad spectrum of Bcl-2 family members, including Bcl-2, Bcl-xL, and Mcl-1. Obatoclax uniquely displaces BH3 domains by activation of the pocket of Mcl-1 followed by a triggering of apoptosis mediated by oligomerization of Bak and release of cytochrome c. Obatoclax is sensitive to Bcl-xL in cell lines lacking it or showing low expression. It shows low cytotoxicity to Mcl-1, Bcl-2, and Bcl-xL in all the strongly-expressed cell lines. Obatoclax inhibits multiple myeloma (MM) cell lines (KMS12PE, KMS18, MY5, etc.) with IC50 values ranging from 52 to 1100 nM and the inhibition is umimpaired even in the presence of IL-6 or IGF-1, which are resistance to cytotoxic agents, at a concentration of 150 nM. Obatoclax enhances the antimyeloma activity induced by melphalan, dexamethasone, or bortezomib. Obatoclax potentiates TRAIL (tumor necrosis factor-related apoptosis-inducing ligand)-mediated apoptosis by unsequestering Bak and Bim from Bcl-2/Bcl-xL or Mcl-1 proteins in PANC-1 and BxPC-3 cells.

 

803712-79-0 - Request Bulk Quote

×
803712-79-0 - Request Bulk Quote
Change